- Poor symptom control
- Frequent severe exacerbations / flare-ups / attacks
- Serious exacerbations (e.g. hospitalisation, ICU stay or mechanical ventilation)
- Airflow limitation
- Controlled asthma that worsens despite additional asthma medication being added
Severe Asthma is Asthma that remains...
Uncontrolled...
Despite treatable factors having been addressed...
And maximal inhaled therapy being taken regularly
Uncontrolled...
Despite treatable factors having been addressed...
- Treatment adherence
- Inhaler device technique
- Self-monitoring
- Trigger avoidance
- Comorbidities identified and managed
And maximal inhaled therapy being taken regularly
- High-dose inhaled corticosteroids (ICS) (e.g. beclomethasone >1000 mcg, budesonide >800mcg ) AND
- Long-acting beta agonists (LABA) or other controller
How Common is Severe Asthma?
It is estimated that between 3-10% of people with asthma have severe disease. Severe asthma is serious problem and a major concern. Severe asthma puts a very heavy burden on individuals and their families (Foster et al. 2017) and on the health system (AIHW, 2015). For more information see the Prevalence & Burden section.
Figure based on data from the Netherlands (Hekking et al. 2015)
LAY OVERVIEW
Not all asthma is the same. Around 3-10% of people with asthma have severe disease. People with severe asthma have symptoms and attacks even when taking high-dose medication. Severe asthma has a major impact on their lives. Symptoms include difficulty breathing, wheezing and coughing. Asthma attacks can lead to hospitalisation and even death. Severe asthma also has an emotional burden. People with severe asthma have high rates of anxiety and depression. Severe asthma also has a major cost on society. Severe asthma reduces people’s ability to work and is a major healthcare cost.
Some Facts About Severe Asthma
Defining the terms
Symptoms
Attacks / Exacerbations / Flare-ups
Phenotypes
Pathophysiology
Defining the terms
Not all asthma is the same. Most people with asthma experience mild to moderate symptoms, and respond well to standard maintenance inhaler therapies. Some people continue to experience poor symptom control or attacks/flare-ups, despite being prescribed maximum doses of maintenance inhaler therapy. For many of these patients, this is because of problems that may be addressed, this is termed ‘difficult-to-treat asthma’. When these factors are managed effectively, some people continue to have frequent symptoms or frequent attacks/flare-ups. This is called ‘severe asthma’ or ‘severe treatment-refractory asthma’.
Symptoms
People with severe asthma experience ongoing symptoms. In Australia, about 45% of adults with a diagnosis of asthma have frequent symptoms (called poor symptom control), and about 30% need to have an urgent visit to their doctor or to a hospital in a year, because of their asthma (Davis et al. 2015).
Attacks / Exacerbations / Flare-ups
People with severe asthma experience frequent worsening of symptoms, termed attacks, flare-ups or exacerbations, which can lead to hospitalisation or even death.
Phenotypes
Asthma differs between individuals due to different underlying disease mechanisms. Identifying the disease mechanisms that are active in an individual patient can be predictive of responses to targeted therapy.
Pathophysiology
Key features of severe asthma pathology include airway inflammation, airway hyper-responsiveness, airway remodelling and mucous hypersecretion.
Key Points
